Apple forecast falls short despite iPhone X optimism
By Bloomberg
02 February 2018 |
7:30 am
Julie Ask, principal analyst at Forrester Research, and Bloomberg's Cory Johnson discuss Apple's earnings and the iPhone X on "Bloomberg Technology."
Related
15 Sep 2018
Nigeria names Power, Works, Housing Minister, Fashola, Chairman, Health Research Foundation.
27 Dec 2018
John Sfakianakis, director of economic research at the Gulf Research Center, discusses oil supply, demand and prices.
21 Apr 2019
Bob O'Donnell, president at TECHnalysis Research, talks about Netflix Inc.'s results and outlook. Netflix delivered a disappointing forecast for the current quarter, with growth in the U.S. slowing to a near-trickle.
10 May 2019
Marci Ryvicker, Wolfe Research managing director, discusses Disney second-quarter earnings and her outlook for the company.
2 Sep 2019
A panel session at the ongoing 59th Annual General Conference of the Nigerian Bar Association focused on space law, exploration and research in Nigeria and the benefit it presents to the country. To discuss his takeaways from the panel session Bart Nnaji, Chairman and CEO of Geometric Power and former Minister of Power in Nigeria joins CNBC Africa’s Christy Cole for more.
21 Nov 2019
Life as a prostitute: Author Emma Becker on working in a brothel to research novel
7 Dec 2019
She's one of the most respected scientists living and working in Africa today. Dr Tebello Nyokong has been awarded South Africa's highest honour, and has received accolades from the African Union and UNESCO for her research into photodynamic therapy and how it can be used to kill cancerous cells without harming any healthy ones. She spoke to us from Johannesburg for Perspective.
8 Feb 2020
Pharmaceuticals are often developed over a long period of time, and can sometimes deliver unexpected effects — as with aspirin and Viagra. Researchers have now used a drug database to discover new anti-cancer substances.
8 Mar 2020
A new HIV treatment, injected every eight weeks, is supposed to reduce stigma and discrimination in Uganda. The drug could be a breakthrough for all those infected — if African leaders are ready to invest.
3 Apr 2020
Genomics research company 54Gene's COVID-19 testing support fund was launched today to increase Nigeria's daily testing capacity. The firm opened the fund with a donation of $150 thousand and has since received an additional $350 thousand from Union Bank. CEO of 54 Gene Abasi Ene-Obong joins CNBC Africa for more.
13 Apr 2020
Coronavirus lockdowns have been touted on social media as helping to fight climate change. But in the Arctic Circle the virus is disrupting climate science. It could leave important gaps in our understanding.
25 May 2020
As the world continues to deal with the effects and impact of several labs and scientists are racing to develop vaccines and drugs for the cure of the novel disease. At the moment, the World Health Organization (WHO) is yet to approve any vaccine or drug for COVID-19, but different investigatory treatments and drugs are being subjected to trials. Here the are top 10 under investigation.
Latest
50 mins ago
Find these stories and much more when you grab a copy of The Guardian on Saturday.
1 hour ago
Ecuador has witnessed heavy rainfall this year, causing almost 1000 dangerous events of landslides and flooding. The latest landslide buried dozens of homes in the country's Andean region.
1 hour ago
Belarusian leader Alexander Lukashenko called for a "truce" without preconditions in Ukraine while warning about nuclear war.
1 hour ago
The security situation in Haiti has spiralled out of control since the shock assassination of President Jovenel Moise in July 2021, with the country increasingly beset by violence. Today, unrest has reached such levels that the United Nations is being urged to intervene and there has been a total breakdown of governance.
3 hours ago
The US Commodity Futures Trading Commission charged the world's biggest crypto exchange and its CEO Changpeng Zhao with "willful evasion" of US law. Zhao has rejected the allegations against him.